Answers are grounded in this paper and cite their sources.
Delivery systems designed to have triggered release after passively targeting the tumor may improve small molecule chemotherapeutic delivery. Particle replication in nonwetting templates was used to prepare nanoparticles to passively target solid tumors in an A549 subcutaneous xenograft model. An acid labile prodrug was delivered to minimize systemic free docetaxel concentrations and improve tolerability without compromising efficacy.
No takes yet. Share an insight, caveat, or question.
Chu et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: